NCT03990428
- Conditions
- Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytosis, +3 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Clinical trial condition
Erdheim-Chester Disease
Explore clinical trials studying Erdheim-Chester Disease. Study availability and eligibility vary by location and protocol.
13 public trials
9 recruiting studies
Erdheim-Chester Disease trial results
Recruiting
Histiocytic Disorder Follow-up Study
NCT05915208
- Conditions
- Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +16 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
NCT07454343
- Conditions
- Erdheim-Chester Disease, Erdheim-Chester Disease (ECD), Hemic and Lymphatic Diseases, +3 more
- Locations
-
- National Institute of Health Bethesda, Maryland, United States
- Mayo Clinic Rochester, Minnesota, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Hopital Pitiè-Salpetriere Paris, France
NCT05093335
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Erdheim-Chester Disease, +22 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT03329274
- Conditions
- Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytosis, +7 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT05768178
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +74 more
- Locations
-
- Belfast City Hospital Belfast, United Kingdom
- University Hospital Birmingham Birmingham, United Kingdom
- Bristol Haematology and Oncology Centre Bristol, United Kingdom
- Addenbrooke's Hospital Cambridge, United Kingdom
NCT06712810
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, Bone Marrow Diseases, +87 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Recruiting
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
NCT04079179
- Conditions
- Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +18 more
- Locations
-
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Benioff Children's Hospital San Francisco, California, United States
NCT02285582
- Conditions
- ALK-positive Histiocytosis, Collagen Diseases, Connective Tissue Diseases, +27 more
- Locations
-
- The University of Alabama at Birmingham Birmingham, Alabama, United States
- Children's Hospital of Los Angeles Los Angeles, California, United States
- Valley Children's Hospital Madera, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Not Yet Recruiting
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
NCT07440290
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +77 more
- Locations
-
- Belfast City Hospital Belfast, United Kingdom
- University Hospital Birmingham Birmingham, United Kingdom
- Birmingham Children's Hospital Birmingham, United Kingdom
- Bristol Royal Hospital for Children Bristol, United Kingdom